Cargando…
Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies
SIMPLE SUMMARY: Long-term quality of life and its potential risk factors in childhood acute lymphoblastic leukemia (ALL) patients remain uncertain. In this cross-sectional study, we investigated daily life quality and life challenges in adult survivors of ALL using multiple self-report questionnaire...
Autores principales: | Sleurs, Charlotte, Musoro, Jammbe, Rowsell, Ali, Kicinski, Michal, Suciu, Stefan, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, van der Werff ten Bosch, Jutte, Rohrlich, Pierre-Simon, Benoit, Yves, Darlington, Anne-Sophie, Piette, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750449/ https://www.ncbi.nlm.nih.gov/pubmed/35008314 http://dx.doi.org/10.3390/cancers14010152 |
Ejemplares similares
-
Quality of life of long‐term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controls
por: Chantziara, Sofia, et al.
Publicado: (2022) -
Socio‐economic outcomes among long‐term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study
por: Barbati, Melissa, et al.
Publicado: (2022) -
Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
por: Mondelaers, Veerle, et al.
Publicado: (2017) -
Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?
por: Levy, Gabriel, et al.
Publicado: (2022) -
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
por: Gamper, Eva M., et al.
Publicado: (2021)